# Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma

> **NCT07111104** · — · COMPLETED · sponsor: **Hopitaux Prives de Metz, Groupe UNEOS** · enrollment: 350 (actual)

## Conditions studied

- Non Small Cell Lung Cancer Metastatic

## Interventions

- **DRUG:** Immunotherapy
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT07111104
- **Lead sponsor:** Hopitaux Prives de Metz, Groupe UNEOS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-14
- **Primary completion:** 2024-10-14
- **Final completion:** 2025-04-28
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07111104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07111104, "Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07111104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*